Trials / Recruiting
RecruitingNCT07433400
Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL
Retrospective Study of the Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Group for Research in Adult Acute Lymphoblastic Leukemia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this retrospective study is to examine the outcome of patients who relapse with Ph+ ALL and to potentially identify response profiles in order toadvance the treatment regimens that can be offered.
Conditions
Timeline
- Start date
- 2025-08-29
- Primary completion
- 2035-12-31
- Completion
- 2035-12-31
- First posted
- 2026-02-25
- Last updated
- 2026-02-25
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07433400. Inclusion in this directory is not an endorsement.